Multi-Cancer Early Detection powered by EV-SERS-AI Platform

EXoPERT CO.,LTD

Seoul, South Korea

EXoPERT is pioneering a new standard in early cancer detection through its integrated EV-SERS-AI platform. Our goal is to make multi-cancer screening accessible, accurate, and affordable for everyone, regardless of location or medical infrastructure. By leveraging label-free Raman spectroscopy and AI-based analysis, we eliminate the need for complex biomarker discovery and reduce costs by over 50%. One of our biggest challenges is ensuring that advanced diagnostics can reach decentralized and resource-limited settings. We ve responded with a streamlined workflow that requires no specialized training and delivers results within hours. Our vision is a world where cancer can be detected early, easily, and globally. From primary care clinics to public health screening sites, EXoPERT is committed to enabling a healthier future through innovation in diagnostic simplicity.